Won Seog Kim

Won Seog Kim

UNVERIFIED PROFILE

Are you Won Seog Kim?   Register this Author

Register author
Won Seog Kim

Won Seog Kim

Publications by authors named "Won Seog Kim"

Are you Won Seog Kim?   Register this Author

100Publications

3175Reads

29Profile Views

The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scores.

Int J Hematol 2019 Oct 27;110(4):438-446. Epub 2019 Jun 27.

Department of Internal Medicine, Dong-A University College of Medicine, 26 Daeshingongwon-ro, Seo-gu, Busan, 49201, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02693-zDOI Listing
October 2019

Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.

BMC Cancer 2019 Oct 10;19(1):936. Epub 2019 Oct 10.

Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-6057-7DOI Listing
October 2019

Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes.

Leuk Lymphoma 2019 Sep 18;60(9):2237-2246. Epub 2019 Feb 18.

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1573998DOI Listing
September 2019

Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma.

Ann Hematol 2019 Sep 6. Epub 2019 Sep 6.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03791-yDOI Listing
September 2019

Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial.

Cancer Res Treat 2019 Aug 13. Epub 2019 Aug 13.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2019.198DOI Listing
August 2019

Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma.

Cancer Res Treat 2019 Apr 10;51(2):547-555. Epub 2018 Jul 10.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473297PMC
April 2019

Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas.

Cancer Res Treat 2019 Apr 20;51(2):611-622. Epub 2018 Jul 20.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473267PMC
April 2019

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance.

Korean J Intern Med 2019 Apr 4. Epub 2019 Apr 4.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2018.196DOI Listing
April 2019

Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma.

Clin Lymphoma Myeloma Leuk 2019 Mar 12;19(3):149-156. Epub 2018 Nov 12.

Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.11.003DOI Listing
March 2019

Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphoma.

Leuk Lymphoma 2019 Feb 6;60(2):317-325. Epub 2018 Jul 6.

a Department of Medicine, Division of Hematology-Oncology , Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1480772DOI Listing
February 2019

Validation of the Marginal Zone Lymphoma International Prognostic Index.

Ann Hematol 2019 Feb 11;98(2):457-464. Epub 2018 Oct 11.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan Universitye, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-018-3516-1
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3516-1DOI Listing
February 2019

Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma.

Cytokine 2019 01 14;113:371-379. Epub 2018 Oct 14.

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2018.10.009DOI Listing
January 2019

Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation.

Biol Blood Marrow Transplant 2018 12 29;24(12):2471-2478. Epub 2018 Jul 29.

Department of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Medical Device Management & Research, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.07.034DOI Listing
December 2018

The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.

Ann Hematol 2018 Dec 1;97(12):2363-2372. Epub 2018 Aug 1.

Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3442-2DOI Listing
December 2018

Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T-cell lymphoma.

Cancer Sci 2018 Dec 28;109(12):3971-3980. Epub 2018 Nov 28.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/cas.13844
Publisher Site
http://dx.doi.org/10.1111/cas.13844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272114PMC
December 2018

Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review.

J Hematol Oncol 2018 12 20;11(1):140. Epub 2018 Dec 20.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-018-0687-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300911PMC
December 2018

Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study.

Cancer Res Treat 2018 Oct 9;50(4):1051-1063. Epub 2017 Nov 9.

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2017.207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192930PMC
October 2018

Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.

Invest New Drugs 2018 10 9;36(5):877-885. Epub 2018 Mar 9.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0582-0DOI Listing
October 2018

Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study.

Ann Hematol 2018 Oct 11;97(10):1851-1857. Epub 2018 Jun 11.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3387-5DOI Listing
October 2018

Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.

Mod Pathol 2018 09 15;31(9):1418-1428. Epub 2018 May 15.

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0064-0DOI Listing
September 2018

Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study.

Bone Marrow Transplant 2018 08 5;53(8):967-976. Epub 2018 Feb 5.

Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0097-5DOI Listing
August 2018

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.

Ann Hematol 2018 Aug 4;97(8):1437-1443. Epub 2018 Apr 4.

Division of Hematology-Oncology, Department of Medicine, Dongsan Medical Center, Keimyung University School of Medicine, 56, Dalseong-ro Jung-gu, Daegu, 700-712, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3317-6DOI Listing
August 2018

Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.

Ann Hematol 2018 Aug 8;97(8):1427-1436. Epub 2018 Apr 8.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3313-xDOI Listing
August 2018

Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell Lymphoma.

Cancer Res Treat 2018 Apr 16;50(2):575-581. Epub 2017 Jun 16.

Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2017.182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912130PMC
April 2018

Use of complementary and alternative medicine by lymphoma survivors in South Korea.

Eur J Oncol Nurs 2018 Apr 20;33:91-96. Epub 2018 Feb 20.

Division of Hematology-Oncology, Inha University Hospital and College of Medicine, Incheon, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejon.2018.01.012DOI Listing
April 2018

Identification of T-cell receptor expression in EBV-positive neoplastic cells in extranodal NK/T-cell lymphoma, nasal-type, and comparison with T-cell receptor gene rearrangement by BIOMED-2 assay.

Hum Pathol 2018 03 16;73:51-58. Epub 2017 Dec 16.

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University, 06351, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.12.006DOI Listing
March 2018

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

Blood Cancer J 2018 02 22;8(2):23. Epub 2018 Feb 22.

Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0056-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823878PMC
February 2018

Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors.

Cancer Res Treat 2018 Jan 30;50(1):204-211. Epub 2017 Mar 30.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2017.0
Publisher Site
http://dx.doi.org/10.4143/crt.2017.091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784625PMC
January 2018

Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma.

Hematol Oncol 2017 Dec 12;35(4):480-486. Epub 2016 Dec 12.

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2374DOI Listing
December 2017

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.

J Clin Oncol 2017 Dec 4;35(35):3898-3905. Epub 2017 Oct 4.

Martin Dreyling, Ludwig Maximilians University of Munich, Munich; Georg Lenz, University Hospital Münster, Münster; Marius Giurescu, Karl Köchert, Henrik Seidel, and Florian Hiemeyer, Bayer AG, Berlin, Germany; Armando Santoro, Humanitas Clinical and Research Center, Rozzano; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; Luigina Mollica, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada; Sirpa Leppä, Helsinki University Central Hospital Cancer Center, Helsinki, Finland; George A. Follows, Addenbrooke's Hospital, Cambridge, United Kingdom; Won Seog Kim, Samsung Medical Center, Seoul, South Korea; Arnon Nagler, Tel Aviv University, Tel HaShomer, Israel; Panayiotis Panayiotidis, National and Kapodistrian University of Athens, Athens, Greece; Judit Demeter, Semmelweis University, Budapest, Hungary; Muhit Özcan, Ankara University School of Medicine, Ankara, Turkey; Marina Kosinova, Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation; Krimo Bouabdallah, University Hospital of Bordeaux, Pessac; Franck Morschhauser, Hôpital Claude Huriez, Lille, France; Don A. Stevens, Norton Cancer Institute, Louisville, KY; David Trevarthen, Comprehensive Cancer Care and Research Institute of Colorado, Englewood, CO; and Lisa Cupit, Li Liu, Carol Peña, Shuxin Yin, Jose Garcia-Vargas, and Barrett H. Childs, Bayer HealthCare Pharmaceuticals, Whippany, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.4648DOI Listing
December 2017

Recent advances in understanding and managing T-cell lymphoma.

F1000Res 2017 12;6:2123. Epub 2017 Dec 12.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Korea, South.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.12573.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728196PMC
December 2017

Brentuximab vedotin: clinical updates and practical guidance.

Blood Res 2017 Dec 26;52(4):243-253. Epub 2017 Dec 26.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2017.52.4.243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762734PMC
December 2017

Atypical presentations of MERS-CoV infection in immunocompromised hosts.

J Infect Chemother 2017 Nov 23;23(11):769-773. Epub 2017 May 23.

Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jiac.2017.04.004DOI Listing
November 2017

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2017 Nov 10;35(31):3529-3537. Epub 2017 Aug 10.

Umberto Vitolo, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin; Angelo Michele Carella, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera e Universitaria San Martino-IST, Genoa; Antonio Pinto, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples; Maurizio Martelli, Sapienza University, Rome, Italy; Marek Trněný, Charles University, General Hospital, Prague; David Belada, Charles University Hospital, Hradec Králové, Czech Republic; John M. Burke, Rocky Mountain Cancer Centers, Aurora, CO; US Oncology Research, The Woodlands, TX; Neil Chua, Cross Cancer Institute, University of Alberta, Edmonton, Alberta; Laurie H. Sehn, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada; Pau Abrisqueta, University Hospital Vall d'Hebron, Barcelona, Spain; Judit Demeter, Semmelweiss University, Budapest, Hungary; Ian Flinn, Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN; Xiaonan Hong, Fudan University Shanghai Cancer Center, Shanghai; Yuan-Kai Shi, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China; Won Seog Kim, Samsung Medical Center, Sunkyunkwan University School of Medicine, Seoul, Republic of Korea; Yoichi Tatsumi, Kinki University Hospital, Osaka, Japan; Mikkel Z. Oestergaard, Günter Fingerle-Rowson, Olivier Catalani, and Tina Nielsen, F. Hoffman-La Roche, Basel, Switzerland; and Michael Wenger, Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.3402DOI Listing
November 2017

Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy.

Jpn J Clin Oncol 2017 11;47(11):995-1001

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx120DOI Listing
November 2017

Macrophage inflammatory protein 1 alpha (MIP-1α) may be associated with poor outcome in patients with extranodal NK/T-cell lymphoma.

Hematol Oncol 2017 Sep 29;35(3):310-316. Epub 2016 Feb 29.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2283DOI Listing
September 2017

Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea.

Korean J Intern Med 2017 Sep 18;32(5):890-899. Epub 2017 Aug 18.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2015.406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583450PMC
September 2017

Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma.

Blood Res 2017 Sep 25;52(3):193-199. Epub 2017 Sep 25.

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2017.52.3.193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641511PMC
September 2017

Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma.

Oncotarget 2017 Sep 17;8(44):76231-76240. Epub 2017 Jul 17.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652701PMC
September 2017

Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma.

Leuk Lymphoma 2017 06 9;58(6):1341-1348. Epub 2016 Oct 9.

a Departments of Nuclear Medicine and Division of Hematology-Oncology , Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Republic of Korea.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2016.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2016.1236380DOI Listing
June 2017

Clinical development of CT-P10 and other biosimilar cancer therapeutics.

Future Oncol 2017 May;13(15s):31-44

CELLTRION Healthcare Co. Ltd, Incheon, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0155DOI Listing
May 2017

Looking to the future and learning lessons from the recent past: changing stakeholder perceptions of biosimilars in cancer.

Future Oncol 2017 May;13(15s):17-29

CELLTRION Healthcare Co. Ltd, Incheon, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0154DOI Listing
May 2017

Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma.

Nutrition 2017 Apr 25;36:67-71. Epub 2016 Jun 25.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nut.2016.06.009DOI Listing
April 2017

The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective.

Blood Res 2017 Mar 27;52(1):3-6. Epub 2017 Mar 27.

Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2017.52.1.3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383584PMC
March 2017

Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm.

Oncotarget 2017 Mar;8(13):22014-22022

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.15782DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400642PMC
March 2017

IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma.

J Cancer 2017 29;8(6):1018-1024. Epub 2017 Mar 29.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.jcancer.org/v08p1018.htm
Publisher Site
http://dx.doi.org/10.7150/jca.17358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436254PMC
March 2017

Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Oncotarget 2017 Feb;8(8):13782-13791

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.14636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355138PMC
February 2017

CD79B limits response of diffuse large B cell lymphoma to ibrutinib.

Leuk Lymphoma 2016 24;57(6):1413-22. Epub 2015 Dec 24.

a Research Institute for Future Medicine, Samsung Medical Center , Sungkyunkwan University School of Medicine , Seoul , Korea ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1113276DOI Listing
January 2017

Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma.

Cancer Res Treat 2017 Jan 9;49(1):92-103. Epub 2016 May 9.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2015.476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266388PMC
January 2017

Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression.

Mod Pathol 2017 01 30;30(1):4-14. Epub 2016 Sep 30.

Department of Pathology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2016.56DOI Listing
January 2017

FOXO4 expression is related to stem cell-like properties and resistance to treatment in diffuse large B-cell lymphoma.

Oncotarget 2017 Jan;8(2):2466-2476

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13690DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356816PMC
January 2017

Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk.

Oncotarget 2017 Jan;8(3):5361-5370

Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.14243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354914PMC
January 2017

Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma.

Acta Haematol 2016 14;136(3):186-90. Epub 2016 Sep 14.

Division of Hemato-Oncology, Department of Internal Medicine, Gyeongsang National University of Medicine and Gyeongsang National University Hospital, Jinju, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000448159DOI Listing
December 2016

Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma.

Oncotarget 2016 Dec;7(52):86433-86445

Department of Pathology, Samsung Medical Center, SungKyunKwan University, Seoul, 06351, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349924PMC
December 2016

Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.

J Infect 2016 11 7;73(5):496-505. Epub 2016 Jul 7.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of School of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinf.2016.06.011DOI Listing
November 2016

Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma.

Int J Hematol 2016 Nov 25;104(5):591-595. Epub 2016 Jul 25.

Division of Hematology-Oncology, Departments of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-016-2068-1DOI Listing
November 2016

Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent update.

F1000Res 2016 8;5. Epub 2016 Aug 8.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University, Seoul, 135-710, Korea, South.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.8790.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979644PMC
September 2016

Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas.

Blood Res 2016 Sep 23;51(3):181-186. Epub 2016 Sep 23.

Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2016.51.3.181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054250PMC
September 2016

Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.

Haematologica 2016 06 27;101(6):757-63. Epub 2016 Jan 27.

Ewha Research Center for Systems Biology (ERCSB), Ewha Womans University, Seoul, Korea Department of Bio-Information Science, Ewha Womans University, Ewha Womans University, Seoul, Korea Department of Life Science, Ewha Womans University, Seoul, Korea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.139253DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013939PMC
June 2016

Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.

Korean J Intern Med 2016 May 22;31(3):560-9. Epub 2016 Feb 22.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2014.222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855088PMC
May 2016

Usefulness of Flow Cytometric Analysis for Detecting Leptomeningeal Diseases in Non-Hodgkin Lymphoma.

Ann Lab Med 2016 May;36(3):209-14

Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3343/alm.2016.36.3.209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773260PMC
May 2016

Clinical Features and Survival of Patients With Follicular Lymphoma in Korea.

Clin Lymphoma Myeloma Leuk 2016 Apr 6;16(4):197-202. Epub 2016 Jan 6.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.12.012DOI Listing
April 2016

Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis.

Cancer Chemother Pharmacol 2016 Apr 16;77(4):865-73. Epub 2016 Mar 16.

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-gu, Seoul, 135-710, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3005-yDOI Listing
April 2016

L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.

J Hematol Oncol 2016 Apr 18;9:41. Epub 2016 Apr 18.

Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0271-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835915PMC
April 2016

Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability.

Ann Hematol 2016 Mar 4;95(4):581-91. Epub 2016 Jan 4.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2581-yDOI Listing
March 2016

Clonal relationships in recurrent B-cell lymphomas.

Oncotarget 2016 Mar;7(11):12359-71

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914290PMC
March 2016

Iron deficient erythropoiesis might play key role in development of anemia in cancer patients.

Oncotarget 2015 Dec;6(40):42803-12

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.5658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767472PMC
December 2015

Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin.

Blood Res 2015 Dec 21;50(4):254-6. Epub 2015 Dec 21.

Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2015.50.4.254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705052PMC
December 2015